Hematology/Oncology Information Center

News

USPSTF Recommends Risk-Reducing Meds for Breast Cancer

USPSTF Recommends Risk-Reducing Meds for Breast Cancer

The USPSTF recommends risk-reducing medications for women at high risk for breast cancer who are at low risk for adverse events, but medications are not recommended for routine use.

Fewer Complications Found With Hybrid Surgery for Esophageal Cancer

Incidence of intraoperative, postoperative complications lower in resectable esophageal cancer.

Risk for Suicide Increased in Year After Cancer Diagnosis

Patients with a cancer diagnosis have an increased risk for suicide during the first year after their diagnosis compared with the general population, with higher suicide rates for cancers with a poor prognosis.

Opinion

Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes

Stool burden can be a particularly challenging aspect of colonoscopies, making potentially cancerous lesions easier to miss.

Soft tissue sarcoma of the thigh in an adolescent male

A young boy's complaint of a tender mass on his left thigh is diagnosed as osteosarcoma.

Transurethral resection of bladder tumor

A transurethral resection of bladder tumor allows examination and determination of histology, depth of invasion, and involvement beyond the bladder.

Clinical Features

Actinic Keratoses: Field Cancerization and Photodynamic Therapy

Actinic Keratoses: Field Cancerization and Photodynamic Therapy

Early treatment of both visible AK lesions and nonvisible sun-damaged skin can eliminate the potential for malignant transformation and decrease the burden of cutaneous squamous cell carcinoma.

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

Although endocrine therapy following surgery is recommended for HR-positive/HER2-negative, axillary node-negative breast cancers, the value of adjuvant chemotherapy in the setting of moderate risk is unclear.

Sign Up for Free e-newsletters